Virtus ETF Advisers’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $342K | Buy |
|
|||||
|
2024
Q3 | $329K | Hold |
|
|||||
|
2024
Q2 | $416K | Sell |
|
|||||
|
2024
Q1 | $522K | Buy |
|
|||||
|
2023
Q4 | $333K | Buy |
|
|||||
|
2023
Q3 | $283K | Sell |
|
|||||
|
2023
Q2 | $302K | Buy |
|
|||||
|
2023
Q1 | $336K | Buy |
|
|||||
|
2022
Q4 | $310K | Sell |
|
|||||
|
2022
Q3 | $404K | Buy |
|
|||||
|
2022
Q2 | $270K | Sell |
|
|||||
|
2022
Q1 | $339K | Hold |
|
|||||
|
2021
Q4 | $391K | Sell |
|
|||||
|
2021
Q3 | $491K | Sell |
|
|||||
|
2021
Q2 | $451K | Buy |
|
|||||
|
2021
Q1 | $275K | Buy |
|
|||||
|
2020
Q4 | $612K | Sell |
|
|||||
|
2020
Q3 | $517K | Buy |
|
|||||
|
2020
Q2 | $540K | Sell |
|
|||||
|
2020
Q1 | $436K | Sell |
|
|||||
|
2019
Q4 | $624K | Sell |
|
|||||
|
2019
Q3 | $436K | Sell |
|
|||||
|
2019
Q2 | $1.03M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $543K | Sell |
|
|||||
|
2018
Q3 | $1.28M | Buy |
|
|||||
|
2018
Q2 | $977K | Sell |
|
|||||
|
2018
Q1 | $1.22M | Sell |
|
|||||
|
2017
Q4 | $996K | Sell |
|
|||||
|
2017
Q3 | $1.42M | Hold |
|
|||||
|
2017
Q2 | $1.05M | Sell |
|
|||||
|
2017
Q1 | $1.02M | Buy |
|
|||||
|
2016
Q4 | $856K | Buy |
|
|||||
|
2016
Q3 | $795K | Hold |
|
|||||
|
2016
Q2 | $247K | Buy |
|
|||||
|
2016
Q1 | $132K | Sell |
|
|||||
|
2015
Q4 | $278K | Buy |
|